Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2020-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
第四届董事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. It details the convening and decisions of the fourth board meeting, including approval of the company's 2020 first quarter report. The document states that the full quarterly report is available on external websites, indicating this document itself is not the full quarterly report but an announcement of the board's approval of it. The document length is short (743 characters), consistent with an announcement rather than a full report. Therefore, this is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the board meeting and report approval, not the report itself.
2020-04-24 Chinese
关于举行2019年度业绩网上说明会的通知
Investor Presentation Classification · 90% confidence The document is a notice about holding an online performance briefing for the fiscal year 2019. It mentions the date and time of the event and invites investors to participate. The document is short (480 characters) and does not contain any financial statements or detailed financial data. It is an announcement of a meeting to discuss the annual performance, not the annual report itself. This fits the definition of an Investor Presentation (IP) as it is a detailed presentation for investors focusing on financials and company performance, even though it is an announcement of the event rather than the presentation content itself. It is not a Report Publication Announcement (RPA) because it does not mention the report being published or attached, but rather the briefing event. Therefore, the best classification is Investor Presentation (IP).
2020-04-24 Chinese
2020年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "浙江华通医药股份有限公司 2020 年第一季度报告全文" which translates to "Zhejiang Huatong Pharmaceutical Co., Ltd. 2020 First Quarter Report Full Text." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2020. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2020
2020-04-24 Chinese
关于重大资产重组相关财务数据有效期延期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the extension of the validity period of financial data related to a major asset restructuring. It references multiple prior announcements and regulatory communications related to the asset restructuring process, including approvals and inquiries from the Shenzhen Stock Exchange and the China Securities Regulatory Commission. The document explains the reason for the extension request, citing the impact of the COVID-19 pandemic on the ability to update audited financial data on time. It does not contain actual financial statements or detailed financial analysis but rather provides an update on the procedural status and regulatory compliance related to the asset restructuring. The document length is 3554 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the extension of financial data validity in the context of a major asset restructuring, not the restructuring report itself or a financial report.
2020-04-22 Chinese
关于使用部分暂时闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the progress of using temporarily idle raised funds for cash management. It details the purchase of structured deposit products with idle raised funds, including amounts, dates, expected yields, and risk control measures. The document is a formal public disclosure about the company's use of raised funds for investment purposes, not a financial report or audit. It does not contain comprehensive financial statements or quarterly/yearly results, nor is it a meeting presentation or voting result. The document length is under 5,000 characters and is primarily an announcement of a specific financing activity related to the use of raised funds. Therefore, it fits best under Capital/Financing Update (CAP).
2020-04-20 Chinese
关于召开2019年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of Zhejiang Huatong Pharmaceutical Co., Ltd. It includes information about the meeting date, time, location, voting procedures (including online voting), agenda items to be discussed and voted on, and instructions for shareholders. The document does not contain financial statements or results but rather the notification and procedural details for the AGM. It explicitly states it is a notice for the 2019 Annual General Meeting and includes agenda items such as the 2019 annual report and profit distribution plan to be discussed at the meeting. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length is about 5,099 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings. Therefore, the correct classification is AGM Information (AGM-R).
2020-04-17 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.